Related Articles
BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer
Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia
Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features
Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.
Epigenetic DNA hypermethylation: Clinical applications in endometrial cancer (Review)